Aspire Biopharma Files S-1 for Securities Registration
Ticker: ASBPW · Form: S-1 · Filed: Apr 9, 2025 · CIK: 1847345
Sentiment: neutral
Topics: sec-filing, s-1, registration
TL;DR
Aspire Biopharma (fka PowerUp Acquisition) filed S-1, get ready for new shares.
AI Summary
Aspire Biopharma Holdings, Inc. filed an S-1 form on April 9, 2025, to register securities. The company, previously known as PowerUp Acquisition Corp., is incorporated in E9 and has a fiscal year end of December 31. Its business address is located at 194 Candelaro Drive, #233, Humacao, PR 00791.
Why It Matters
This S-1 filing indicates Aspire Biopharma Holdings, Inc. is preparing to offer securities to the public, which could impact its capital structure and future growth prospects.
Risk Assessment
Risk Level: medium — S-1 filings are standard for IPOs or secondary offerings, but the specific details of Aspire Biopharma's business and financial health are not yet fully disclosed in this initial filing.
Key Numbers
- 20250409 — Filing Date (Indicates the date Aspire Biopharma Holdings, Inc. submitted its S-1 filing.)
- 1231 — Fiscal Year End (Specifies the end of Aspire Biopharma Holdings, Inc.'s annual accounting period.)
Key Players & Entities
- Aspire Biopharma Holdings, Inc. (company) — Filer of the S-1 registration statement
- PowerUp Acquisition Corp. (company) — Former name of Aspire Biopharma Holdings, Inc.
- 0001641172-25-003291 (filing_id) — Accession number for the S-1 filing
- April 9, 2025 (date) — Date the S-1 filing was submitted
- 194 Candelaro Drive, #233, Humacao, PR 00791 (address) — Business and mailing address of Aspire Biopharma Holdings, Inc.
FAQ
What is the purpose of this S-1 filing for Aspire Biopharma Holdings, Inc.?
The S-1 filing is a registration statement filed with the SEC to register securities for public offering.
What was Aspire Biopharma Holdings, Inc. previously known as?
Aspire Biopharma Holdings, Inc. was formerly known as PowerUp Acquisition Corp.
When was the name change from PowerUp Acquisition Corp. to Aspire Biopharma Holdings, Inc.?
The filing indicates a date of name change as 20210222, suggesting the change occurred on February 22, 2021.
Where is Aspire Biopharma Holdings, Inc. located?
The company's business and mailing address is 194 Candelaro Drive, #233, Humacao, PR 00791.
What is the SIC code for Aspire Biopharma Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Aspire Biopharma Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form S-1 (Form S-1) was filed with the SEC on April 9, 2025 regarding Aspire Biopharma Holdings, Inc. (ASBPW).